Susquehanna International Group’s iTeos Therapeutics ITOS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.44M | Buy |
144,080
+107,772
| +297% | +$1.07M | ﹤0.01% | 2737 |
|
|
2025
Q1 | $217K | Sell |
36,308
-197,568
| -84% | -$1.18M | ﹤0.01% | 5437 |
|
|
2024
Q4 | $1.8M | Buy |
233,876
+214,336
| +1,097% | +$1.65M | ﹤0.01% | 2128 |
|
|
2024
Q3 | $200K | Sell |
19,540
-89,535
| -82% | -$914K | ﹤0.01% | 4814 |
|
|
2024
Q2 | $1.62M | Buy |
109,075
+83,872
| +333% | +$1.24M | ﹤0.01% | 1978 |
|
|
2024
Q1 | $344K | Sell |
25,203
-260,115
| -91% | -$3.55M | ﹤0.01% | 4004 |
|
|
2023
Q4 | $3.12M | Buy |
285,318
+192,592
| +208% | +$2.11M | ﹤0.01% | 1491 |
|
|
2023
Q3 | $1.02M | Buy |
92,726
+18,345
| +25% | +$201K | ﹤0.01% | 2549 |
|
|
2023
Q2 | $985K | Buy |
74,381
+23,138
| +45% | +$306K | ﹤0.01% | 2743 |
|
|
2023
Q1 | $697K | Buy |
51,243
+10,996
| +27% | +$150K | ﹤0.01% | 3379 |
|
|
2022
Q4 | $786K | Sell |
40,247
-915
| -2% | -$17.9K | ﹤0.01% | 2601 |
|
|
2022
Q3 | $784K | Buy |
41,162
+23,347
| +131% | +$445K | ﹤0.01% | 2889 |
|
|
2022
Q2 | $367K | Sell |
17,815
-10,452
| -37% | -$215K | ﹤0.01% | 3729 |
|
|
2022
Q1 | $910K | Sell |
28,267
-48,583
| -63% | -$1.56M | ﹤0.01% | 2936 |
|
|
2021
Q4 | $3.58M | Buy |
+76,850
| New | +$3.58M | ﹤0.01% | 1458 |
|
|
2021
Q3 | – | Sell |
-26,939
| Closed | -$691K | – | 5705 |
|
|
2021
Q2 | $691K | Buy |
26,939
+6,747
| +33% | +$173K | ﹤0.01% | 3488 |
|
|
2021
Q1 | $690K | Buy |
+20,192
| New | +$690K | ﹤0.01% | 3463 |
|